Coronary Model Shows Limits in Cath-Referred Patients
-
By
-
Andrea Surnit
-
June 22, 2026
-
5 min
By
Andrea Surnit
June 22, 2026
Investigators compared cardiovascular outcomes with tirzepatide and a placebo proxy in patients with type 2 diabetes and established atherosclerotic cardiovascular disease.
August 28, 2026
Several FDA decisions across multiple specialties are expected this month.
August 28, 2026